Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry

Intensive Care Medicine(2021)10.1007/s00134-021-06471-6Source: DataRank Database

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry is a research paper published in Intensive Care Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.09)OA: bronzeTopics (40)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (27)

Joost Wauters ORCID,Daniele Roberto Giacobbe ORCID,Katrien Lagrou ORCID,Martin Hoenigl ORCID,on behalf of the ECMM-CAPA Study Group

Live enrichment

PubMed:34269853 PMC:PMC8284037 OpenAlex:https://openalex.org/W3177696589

national institutes of health

Grant: UL1TR001442-061

National Institutes of Health

Grant: 2UL1TR001442-06

UC San Diego Clinical and Translational Research Institute

gilead sciences

astellas pharma us

FWCI

3.09

Citation Percentile

0.9%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

bronzeLicense: Springer TDM

journalhttps://link.springer.com/content/pdf/10.1007/s00134-021-06471-6.pdf

BRONZEhttps://link.springer.com/content/pdf/10.1007/s00134-021-06471-6.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00134-021-06471-6.pdf

publisherhttps://link.springer.com/article/10.1007/s00134-021-06471-6/fulltext.html

journalhttps://doi.org/10.1007/s00134-021-06471-6

Fields of Study

Antifungal resistance and susceptibilityAntimicrobial Resistance in StaphylococcusNosocomial Infections in ICUMedicineEnvironmental Science0303 health sciences03 medical and health sciencesCOVID-19Critical IllnessHumansMycologyRegistriesSARS-CoV-2

MeSH Terms

COVID-19SARS-CoV-2HumansMycologyRegistriesCritical Illness

Keywords

MedicineAnesthesiologyIntensive care unitIntensive careIntensive care medicineBronchoalveolar lavageCohortRespiratory failurePediatricsEmergency medicineInternal medicineLungPathologyLetterSARS-CoV-2Critical IllnessCritical Illness; Humans; Registries; SARS-CoV-2; COVID-19; MycologyCOVID-19HumansMycologyRegistries

Sustainable Development Goals

SDG 0: Zero hunger

Additional file 1 of Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID)

10.6084/m9.figshare.26673879.v1figshare

Additional file 1 of Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID)

10.6084/m9.figshare.26673879figshare